Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Expanded_access × ruxolitinib × Myeloid × Clear all

Status

No longer available 1 Available 1

Sponsor Class

Study Type

Interventional 62 Observational 5 Expanded_access 2

Sponsor

Cancer Type

Conditions

Polycythemia Vera 2 Primary Myelofibrosis 1

Interventions

nilotinib 3 ruxolitinib 2 venetoclax 1 selinexor 1 ponatinib 1 navitoclax 1 midostaurin 1 fludarabine phosphate 1 asciminib 1 Whole-Body Irradiation 1 Tacrolimus 1 Mycophenolic Acid 1 Cytarabine 1 Cord Blood Stem Cell Transplantation 1 Busulfan 1 Bone Marrow Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04745637 2025-11-18

Managed Access Programs for INC424, Ruxolitinib

Novartis

Polycythemia Vera, Primary Myelofibrosis

NCT05269771 2025-11-05

MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera

Novartis

No longer available

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡